135 related articles for article (PubMed ID: 32388856)
1. Clinical correlates of fatigue in chronic inflammatory demyelinating polyneuropathy.
Lawley A; Abbas A; Seri S; Rajabally YA
Muscle Nerve; 2020 Aug; 62(2):226-232. PubMed ID: 32388856
[TBL] [Abstract][Full Text] [Related]
2. Fatigue in chronic inflammatory demyelinating polyneuropathy.
Gable KL; Attarian H; Allen JA
Muscle Nerve; 2020 Dec; 62(6):673-680. PubMed ID: 32710648
[TBL] [Abstract][Full Text] [Related]
3. Peripheral nerve electrophysiology studies in relation to fatigue in patients with chronic inflammatory demyelinating polyneuropathy.
Lawley A; Abbas A; Seri S; Rajabally YA
Clin Neurophysiol; 2020 Dec; 131(12):2926-2931. PubMed ID: 32928696
[TBL] [Abstract][Full Text] [Related]
4. Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bozovic I; Kacar A; Peric S; Nikolic A; Bjelica B; Cobeljic M; Petrovic M; Stojanov A; Djuric V; Stojanovic M; Djordjevic G; Martic V; Dominovic A; Vukojevic Z; Basta I
J Neurol; 2017 Dec; 264(12):2481-2486. PubMed ID: 29086018
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Serbian version of inflammatory Rasch-built overall disability scale in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Peric S; Bozovic I; Pruppers MHJ; Bjelica B; Stevic Z; Faber CG; Merkies ISJ; Basta I
J Peripher Nerv Syst; 2019 Sep; 24(3):260-267. PubMed ID: 31397933
[TBL] [Abstract][Full Text] [Related]
6. Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy.
Klehmet J; Tackenberg B; Haas J; Kieseier BC
BMC Neurol; 2023 May; 23(1):207. PubMed ID: 37237267
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classes.
Alabdali M; Abraham A; Alsulaiman A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
J Neurol Sci; 2017 Jan; 372():223-227. PubMed ID: 28017218
[TBL] [Abstract][Full Text] [Related]
8. Chronic Acquired Polyneuropathy Patient Reported Index (CAPPRI) in chronic inflammatory demyelinating polyradiculoneuropathy.
Bjelica B; Peric S; Gwathmey K; Sadjadi R; Bozovic I; Burns TM; Basta I
J Peripher Nerv Syst; 2019 Sep; 24(3):247-252. PubMed ID: 31209940
[TBL] [Abstract][Full Text] [Related]
9. Does grip strength reflect isokinetic muscle strength in lower limbs in patients with chronic inflammatory demyelinating polyneuropathy?
Knak KL; Andersen LK; Christiansen I; Markvardsen LK
Muscle Nerve; 2018 Sep; 58(3):449-452. PubMed ID: 29603302
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and determinants of pain in chronic inflammatory demyelinating polyneuropathy: Results from the German INHIBIT registry.
Mork H; Motte J; Fisse AL; Grüter T; Brünger J; Stoykova Z; Bulut Y; Athanasopoulos D; Sturm D; Tegenthoff M; Gold R; Enax-Krumova E; Pitarokoili K
Eur J Neurol; 2022 Jul; 29(7):2109-2120. PubMed ID: 35357725
[TBL] [Abstract][Full Text] [Related]
11. Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP.
Garssen MP; Bussmann JB; Schmitz PI; Zandbergen A; Welter TG; Merkies IS; Stam HJ; van Doorn PA
Neurology; 2004 Dec; 63(12):2393-5. PubMed ID: 15623709
[TBL] [Abstract][Full Text] [Related]
12. Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.
Klehmet J; Beutner S; Hoffmann S; Dornauer M; Paul F; Reilmann R; Brandt AU; Meisel A
BMC Neurol; 2019 Jun; 19(1):118. PubMed ID: 31176377
[TBL] [Abstract][Full Text] [Related]
13. Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Merkies IS; Kieseier BC
Eur Neurol; 2016; 75(3-4):199-206. PubMed ID: 27077919
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in inflammatory neuropathies: the IN-QoL.
Draak THP; Faber CG; Merkies ISJ;
J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):256-262. PubMed ID: 28986470
[TBL] [Abstract][Full Text] [Related]
15. Motor unit number index (MUNIX) in chronic inflammatory demyelinating polyneuropathy: A potential role in monitoring response to intravenous immunoglobulins.
Lawley A; Seri S; Rajabally YA
Clin Neurophysiol; 2019 Oct; 130(10):1743-1749. PubMed ID: 31400577
[TBL] [Abstract][Full Text] [Related]
16. Muscle performance relates to physical function and quality of life in long-term chronic inflammatory demyelinating polyradiculoneuropathy.
Harbo T; Andersen H; Overgaard K; Jakobsen J
J Peripher Nerv Syst; 2008 Sep; 13(3):208-17. PubMed ID: 18844787
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin.
Ryltoft AK; Al-Zuhairy A; Sindrup SH; Andersen H; Markvardsen LK
Acta Neurol Scand; 2020 Dec; 142(6):637-640. PubMed ID: 33404110
[TBL] [Abstract][Full Text] [Related]
18. Reductions in muscle quality and quantity in chronic inflammatory demyelinating polyneuropathy patients assessed by magnetic resonance imaging.
Gilmore KJ; Doherty TJ; Kimpinski K; Rice CL
Muscle Nerve; 2018 Sep; 58(3):396-401. PubMed ID: 29742800
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Draak TH; Gorson KC; Vanhoutte EK; van Nes SI; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
Eur J Neurol; 2016 Jul; 23(7):1248-53. PubMed ID: 27129110
[TBL] [Abstract][Full Text] [Related]
20. Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study.
Merkies IS; Hughes RA; Donofrio P; Bril V; Dalakas MC; Hanna K; Hartung HP; Latov N; van Doorn PA; Deng C;
J Peripher Nerv Syst; 2010 Sep; 15(3):208-15. PubMed ID: 21040143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
